Sonoma Pharmaceuticals, Inc.
NASDAQ: SNOA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Amy Trombly
- Employees
- 10
- Headquarters
- Woodstock, United States
- IPO year
- 2007
- Market cap
- $1.9M
- Website
- https://www.sonomapharma.com
Loading SNOA…
Loading profile data…Frequently asked questions about SNOA
What does Sonoma Pharmaceuticals, Inc. (SNOA) do?
Sonoma Pharmaceuticals, Inc. specializes in the creation and distribution of stabilized hypochlorous acid (HOCl) products. These offerings address a diverse range of medical and health needs, including wound management, veterinary care, ocular hygiene, oral health, and various dermatological conditions. The company's market reach extends across...
Where does SNOA trade?
Sonoma Pharmaceuticals, Inc. (SNOA) trades on the NASDAQ Capital Market.
What sector is SNOA in?
Sonoma Pharmaceuticals, Inc. (SNOA) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Sonoma Pharmaceuticals, Inc.?
Amy Trombly is the chief executive officer of Sonoma Pharmaceuticals, Inc. (SNOA).
Where is Sonoma Pharmaceuticals, Inc. headquartered?
Sonoma Pharmaceuticals, Inc. is headquartered in United States.
Does SNOA pay a dividend?
Sonoma Pharmaceuticals, Inc. (SNOA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SNOA go public?
Sonoma Pharmaceuticals, Inc. (SNOA) completed its initial public offering in 2007.